Côte d’Ivoire will receive 157.9 million euros (US$186.4 million) in funding from the Global Fund to combat HIV, tuberculosis and malaria between 2027 and 2029, officials said.
The financing, part of the Global Fund’s eighth grant cycle, was announced by Danielle Adjafi, head of the Country Coordinating Mechanism, at a press briefing in Abidjan.
The funds will support national health programmes, with 53 million euros allocated to HIV, 10.8 million euros to tuberculosis, and 94.1 million euros to malaria, while additional resources are expected to strengthen the broader health system.
The support reflects continued international backing for Côte d’Ivoire’s long-term public health strategy, which has recorded significant gains over the past two decades.
According to Global Fund data, AIDS-related deaths in the country have fallen by 83 percent since 2002, while new HIV infections have declined by nearly 90 percent over the same period. Tuberculosis cases have also dropped by about 40 percent.
More Read
Malaria, however, remains a major public health challenge in the West African nation, driving continued investment in prevention measures such as insecticide-treated mosquito nets and expanded awareness campaigns.
Health authorities say sustained donor support has been central to improving access to treatment and strengthening the country’s healthcare system, particularly in rural and high-risk areas.
The latest allocation follows earlier commitments, including six grants worth a total of 230 million euros signed in March 2024 for the 2024–2026 period with the Ministry of Health, Public Hygiene and Universal Health Coverage.
More Read
Officials say the continued partnership with the Global Fund remains critical to maintaining progress against infectious diseases while reinforcing health system resilience.
Public health experts note that despite strong gains in HIV and tuberculosis control, malaria continues to place a heavy burden on healthcare services and remains a key focus of national and donor-funded programmes.
The Global Fund’s ongoing support is expected to help Côte d’Ivoire sustain momentum in disease reduction while addressing gaps in prevention, diagnostics and treatment coverage.
The new funding cycle comes as African countries continue to rely on blended financing from international partners to sustain progress in communicable disease control and broader health system strengthening efforts.
